Last reviewed · How we verify

NCT05163444

Gait Analysis of Hemiparetics Adults Patients With Quadripod Cane and Rolling Cane

Status unknown NA Last updated 24 May 2022
What this trial tests

NA trial testing Gait analysis with rolling cane in Stroke in 30 participants. Status unknown.

Timeline
26 February 2022
Primary endpoint
31 March 2023
31 March 2023

Quick facts

Lead sponsorUniversity of Liege
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingnone
Primary purposeother
Enrollment30
Start date26 February 2022
Primary completion31 March 2023
Estimated completion31 March 2023
Sites2 locations across Belgium

Drugs / interventions tested

Conditions studied

Sponsor

University of Liege

Who can join

18 and older, any sex, with Stroke or Hemiplegic Gait. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

After stroke, a lot of patients present an hemiparesis and gait disorders. They need walking aids like quadripod cane or rolling cane. The quadripod cane confers a great stability but implies a walk in 3 times, thus consume more energy. The pause time necessary for the displacement (uplift) of the cane disappear with the Wheeleo. The investigators will study many spatio-temporal parameters to determine which one allows to decrease the walking speed.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Gait Analysis of Hemiparetic Adult Patients with a Quadripod Cane and a Rolling Cane.
    Maillard B, Boutaayamou M, Cassol H, Pirnay L, et al · · 2024 · cited 1× · PMID 38391839 · DOI 10.3390/healthcare12040464

Verify or expand the search:

Other recruiting trials for Stroke

Currently open trials in the same condition.

Other University of Liege trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05163444.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing